Cellebrite DI Ltd. Class A Ordinary Shares
Here’s whether Cellebrite DI Ltd. Class A Ordinary Shares (CLBT) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.78% over 10 days); RSI 75 — overbought, elevated pullback risk; weak 1-year return of -32.8%; 3-month momentum negative (-10.4%). Currently 35.0% off its 52-week high. Score: -7/7.
CLBT is trading below its 200-day MA ($15.97) — a key warning sign the longer-term trend is under pressure. With an RSI of 75.1, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -32.8% compares to +27.9% for SPY (trailed the market by 60.7%). The current 35.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.